Oosterlinck, W., & Decaestecker, K. (2018). An immediate intravesical instillation of mitomycin C is of benefit in all prognostic risk groups with non-muscle-invasive bladder cancers. Transl Androl Urol.
Dyfyniad Arddull ChicagoOosterlinck, Willem, and Karel Decaestecker. "An Immediate Intravesical Instillation of Mitomycin C Is of Benefit in All Prognostic Risk Groups With Non-muscle-invasive Bladder Cancers." Transl Androl Urol 2018.
Dyfyniad MLAOosterlinck, Willem, and Karel Decaestecker. "An Immediate Intravesical Instillation of Mitomycin C Is of Benefit in All Prognostic Risk Groups With Non-muscle-invasive Bladder Cancers." Transl Androl Urol 2018.
Rhybudd: Mae'n bosib nad yw'r dyfyniadau hyn bob amser yn 100% cywir.